Cronos Group Inc (CRON) - Net Assets
Based on the latest financial reports, Cronos Group Inc (CRON) has net assets worth CA$1.13 Billion CAD (≈ $818.91 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$1.18 Billion ≈ $852.44 Million USD) and total liabilities (CA$46.36 Million ≈ $33.54 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Cronos Group Inc's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$1.13 Billion |
| % of Total Assets | 96.07% |
| Annual Growth Rate | 90.89% |
| 5-Year Change | -34.96% |
| 10-Year Change | 13074.82% |
| Growth Volatility | 340.89 |
Cronos Group Inc - Net Assets Trend (2013–2024)
This chart illustrates how Cronos Group Inc's net assets have evolved over time, based on quarterly financial data. Also explore CRON total asset value for the complete picture of this company's asset base.
Annual Net Assets for Cronos Group Inc (2013–2024)
The table below shows the annual net assets of Cronos Group Inc from 2013 to 2024. For live valuation and market cap data, see CRON company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$1.11 Billion ≈ $803.67 Million |
+1.36% |
| 2023-12-31 | CA$1.10 Billion ≈ $792.92 Million |
-3.93% |
| 2022-12-31 | CA$1.14 Billion ≈ $825.36 Million |
-14.49% |
| 2021-12-31 | CA$1.33 Billion ≈ $965.19 Million |
-21.89% |
| 2020-12-31 | CA$1.71 Billion ≈ $1.24 Billion |
-2.34% |
| 2019-12-31 | CA$1.75 Billion ≈ $1.27 Billion |
+1025.61% |
| 2018-12-31 | CA$155.39 Million ≈ $112.40 Million |
+126.24% |
| 2017-12-31 | CA$68.68 Million ≈ $49.68 Million |
+174.12% |
| 2016-12-31 | CA$25.06 Million ≈ $18.13 Million |
+197.13% |
| 2015-12-31 | CA$8.43 Million ≈ $6.10 Million |
+5.88% |
| 2014-12-31 | CA$7.96 Million ≈ $5.76 Million |
+779.66% |
| 2013-12-31 | CA$905.41K ≈ $654.96K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Cronos Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 45832847500.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CA$457.71 Million | 43.02% |
| Common Stock | CA$669.88 Million | 62.95% |
| Other Comprehensive Income | CA$-63.52 Million | -5.97% |
| Total Equity | CA$1.06 Billion | 100.00% |
Cronos Group Inc Competitors by Market Cap
The table below lists competitors of Cronos Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Jiangsu Tongli Risheng Machinery Co. Ltd.
SHG:605286
|
$1.00 Billion |
|
Tortoise Energy Infrastructure Closed Fund
NYSE:TYG
|
$1.00 Billion |
|
Fujian Tianma Science and Technology Group Co Ltd
SHG:603668
|
$1.00 Billion |
|
CareDx Inc
NASDAQ:CDNA
|
$1.00 Billion |
|
B-Soft Co Ltd
SHE:300451
|
$999.68 Million |
|
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151
|
$999.65 Million |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
$999.60 Million |
|
WCON Electronics (Guangdong) Co. Ltd. A
SHE:301328
|
$999.59 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cronos Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,099,571,000 to 1,064,063,000, a change of -35,508,000 (-3.2%).
- Net income of 41,041,005 contributed positively to equity growth.
- Other comprehensive income decreased equity by 84,203,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$41.04 Million | +3.86% |
| Other Comprehensive Income | CA$-84.20 Million | -7.91% |
| Other Changes | CA$7.65 Million | +0.72% |
| Total Change | CA$- | -3.23% |
Book Value vs Market Value Analysis
This analysis compares Cronos Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.30x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 50.83x to 1.30x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CA$0.07 | CA$3.61 | x |
| 2014-12-31 | CA$0.25 | CA$3.61 | x |
| 2015-12-31 | CA$0.19 | CA$3.61 | x |
| 2016-12-31 | CA$0.32 | CA$3.61 | x |
| 2017-12-31 | CA$0.39 | CA$3.61 | x |
| 2018-12-31 | CA$0.90 | CA$3.61 | x |
| 2019-12-31 | CA$5.10 | CA$3.61 | x |
| 2020-12-31 | CA$4.87 | CA$3.61 | x |
| 2021-12-31 | CA$3.61 | CA$3.61 | x |
| 2022-12-31 | CA$3.09 | CA$3.61 | x |
| 2023-12-31 | CA$2.89 | CA$3.61 | x |
| 2024-12-31 | CA$2.78 | CA$3.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cronos Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 34.93%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 1.10x
- Recent ROE (3.86%) is above the historical average (-10.55%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -68.42% | 0.00% | -0.15x | 1.42x | CA$-710.02K |
| 2014 | -54.43% | 0.00% | -0.07x | 1.08x | CA$-5.13 Million |
| 2015 | 3.31% | 11.34% | 0.23x | 1.26x | CA$-564.53K |
| 2016 | -3.51% | -214.80% | 0.01x | 1.27x | CA$-3.39 Million |
| 2017 | -2.13% | -47.12% | 0.04x | 1.17x | CA$-8.33 Million |
| 2018 | -15.05% | -178.50% | 0.07x | 1.23x | CA$-38.90 Million |
| 2019 | 65.01% | 4911.60% | 0.01x | 1.19x | CA$962.64 Million |
| 2020 | -4.26% | -156.55% | 0.02x | 1.13x | CA$-244.04 Million |
| 2021 | -29.37% | -613.54% | 0.05x | 1.05x | CA$-526.53 Million |
| 2022 | -14.88% | -194.51% | 0.07x | 1.06x | CA$-284.65 Million |
| 2023 | -6.71% | -84.78% | 0.08x | 1.04x | CA$-183.74 Million |
| 2024 | 3.86% | 34.93% | 0.10x | 1.10x | CA$-65.37 Million |
Industry Comparison
This section compares Cronos Group Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $107,805,152
- Average return on equity (ROE) among peers: -33.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cronos Group Inc (CRON) | CA$1.13 Billion | -68.42% | 0.04x | $999.89 Million |
| Aurora Cannabis Inc (ACB) | $1.37 Million | -23.49% | 0.01x | $193.63 Million |
| Amotiv Limited (AOV) | $991.21 Million | 1.74% | 0.01x | $553.67 Million |
| Aequus Pharmaceuticals Inc (AQS) | $1.68 Million | -166.73% | 0.19x | $479.73K |
| Avicanna Inc (AVCN) | $29.88 Million | -74.35% | 0.51x | $13.17 Million |
| Avant Brands Inc (AVNT) | $47.87 Million | -23.47% | 0.06x | $4.13 Million |
| Bausch Health Companies Inc (BHC) | $-322.00 Million | 0.00% | 0.00x | $2.06 Billion |
| CanadaBis Capital Inc (CANB) | $7.34 Million | 60.52% | 2.13x | $1.53 Million |
| Cannabist Company Holdings Inc (CBST) | $286.95 Million | -35.14% | 1.54x | $12.59 Million |
| Cipher Pharmaceuticals Inc (CPH) | $11.47 Million | 0.49% | 0.41x | $326.62 Million |
| Cardiol Therapeutics Inc Class A (CRDL) | $22.27 Million | -71.36% | 0.11x | $148.65 Million |
About Cronos Group Inc
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.